Current live recombinant RSV vaccine candidates based on attenuated RSV (A–D) or on the attenuated bovine/human parainfluenza virus (B/HPIV) type 3 virus expressing RSV F from an inserted gene (drawn immediately over its site of insertion). RSV genes and ORFs are represented by lightly shaded rectangles, BPIV3 genes are represented by open rectangles, and HPIV3 genes are represented by darkly shaded rectangles. Gene deletions are demarcated with dotted vertical lines. The locations of attenuating cp, 248, 404, and 1030 mutations are indicated.